US20070125711A1 - Novel separation matrix - Google Patents

Novel separation matrix Download PDF

Info

Publication number
US20070125711A1
US20070125711A1 US10/575,945 US57594504A US2007125711A1 US 20070125711 A1 US20070125711 A1 US 20070125711A1 US 57594504 A US57594504 A US 57594504A US 2007125711 A1 US2007125711 A1 US 2007125711A1
Authority
US
United States
Prior art keywords
support
gradient
ligands
ligand
separation matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/575,945
Other languages
English (en)
Inventor
Jan Bergstrom
Gunnar Glad
Bo-Lennart Johansson
Anders Ljunglof
Jean-Luc Maloisel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Global Life Sciences Solutions USA LLC
Original Assignee
GE Healthcare Bio Sciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Bio Sciences Corp filed Critical GE Healthcare Bio Sciences Corp
Assigned to GE HEALTHCARE BIO-SCIENCES AB reassignment GE HEALTHCARE BIO-SCIENCES AB ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BERGSTROM, JAN, GLAD, GUNNAR, JOHANSSON, BO-LENNART, LJUNGLOF, ANDERS, MALOISEL, JEAN-LUC
Publication of US20070125711A1 publication Critical patent/US20070125711A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
    • B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
    • B01J20/3285—Coating or impregnation layers comprising different type of functional groups or interactions, e.g. different ligands in various parts of the sorbent, mixed mode, dual zone, bimodal, multimodal, ionic or hydrophobic, cationic or anionic, hydrophilic or hydrophobic
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
    • B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
    • B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
    • B01J20/3244—Non-macromolecular compounds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B01D15/364—Amphoteric or zwitterionic ion-exchanger

Definitions

  • the present invention relates to a novel separation matrix for isolation of target molecules, such as proteins, from a liquid.
  • the invention also encompasses a method of preparing such a matrix as well as a chromatography column packed with such as separation matrix.
  • Biotechnological methods are used to an increasing extent in the production of proteins, peptides, nucleic acids and other biological compounds, for research purposes as well as in order to prepare novel kinds of drugs. Due to its versatility and sensitivity to the compounds, chromatography is often the preferred purification method in this context.
  • the term chromatography embraces a family of closely related separation methods, which are all based on the principle that two mutually immiscible phases are brought into contact. More specifically, the target compound is introduced into a mobile phase, which is contacted with a stationary phase. The target compound will then undergo a series of interactions between the stationary and mobile phases as it is being carried through the system by the mobile phase. The interactions exploit differences in the physical or chemical properties of the components in the sample.
  • the target compound is present in a liquid together with one or more contaminants or undesired substances.
  • Said liquid is contacted with a stationary phase, known as a matrix, which is commonly comprised of either a collection of homogenous, porous or non-porous particles or a monolith of organic or inorganic origin.
  • a separation matrix is comprised of a support to which groups capable of interaction with the target and known as ligands have been coupled.
  • the ligands will impart to the supports the ability to effect the separation, identification, and/or purification of molecules of interest.
  • a number of different techniques for controlling the density of ligands on a support have been suggested, which techniques generally fall into one of the following four categories:
  • a disadvantage of this method is that in order not to favour ligand over quencher, an understanding of the reaction kinetics for ligand and reaction kinetics for quencher will be required, including the rate constant for coupling, the concentration of ligand, the nucleophilicity of ligand and quencher, etc.
  • U.S. Pat. No. 6,426,315 (Bergström et al.) suggests to replace such a series of steps by using a multifunctional porous separation matrix, i.e. to present the different kind of matrices on a single separation matrix. More specifically, U.S. Pat. No. 6,426,315 relates to a process for preparing such multifunctional porous separation matrices by introducing different functionalities in different layers of the matrix.
  • the process includes contacting a separation matrix that comprises reactive groups with a reagent, the amount of which is not sufficient for reaction with all groups present in the matrix, and wherein the reaction between the reagent and said reactive groups is rapid compared to the mass transport of the reagent within the matrix.
  • the reactive groups may e.g. be hydroxyl groups, double bonds etc, while the reagent may be a compound that introduces a desired functionality within the matrix, directly or indirectly.
  • the reagent is a compound known as an activating agent, such as a halogenating agent, and the desired functionality is then introduced in a subsequent step.
  • the most preferred functionalities are groups that provide desired separation characteristics to the matrix, commonly known as ligands.
  • the functionalities introduced are the degree of crosslinking, the density or the porosity of the matrix.
  • the reactive groups may be further reacted with another reagent.
  • the method according to U.S. Pat. No. 6,426,315 may exhibit the drawbacks discussed above under a) and b).
  • the teachings of U.S. Pat. No. 6,426,315 enable the construction of a separation matrix which exhibits a multitude of functions, each one of which will provide different properties as regards binding and diffusion in a separation process, there is no guidance in U.S. Pat. No. 6,426,315 with regard to how to manufacture a separation matrix to that provides an optimal mass transport within the matrix.
  • the ionisable functionality is partially electrostatically charged at the pH of adsorption of the target compound to the resin, and is either further charged or of opposite charge at the pH of desorption of the compound from the resin.
  • the ionisable functionalities are selected from a specified group of possible functionalities.
  • the ionisable functional group is derived from either 2-mercapto-1-methylimidazole or ( ⁇ )phenylpropanolamine and coupled to a density of at least 150 ⁇ mol per millilitre of resin.
  • Such a high ligand density is stated to provide a sufficient hydrophobicity to adsorb target compounds without the need of adding excessive amounts of salt to the liquid.
  • U.S. Pat. No. 5,945,520 discloses multifunctional ligands evenly coupled to a resin, which consequently can be described as a homogenous separation matrix.
  • U.S. Pat. No. 6,528,322 (Carlsson et al) relates to an analytical method for qualitative, semiquantitative or quantitative determination of at least two analytes in an aqueous sample by thin layer chromatography (TLC). More specifically, a method is disclosed wherein analytes, such as isoforms, in an aqueous sample are separated in a flow matrix which permits capillary force assisted fluid flow therethrough, especially a planar flow matrix such as a chromatographic membrane.
  • the gist of the invention is stated to be that the separated analytes are eluted from the separation area of the flow matrix in a direction substantially transverse to the separation direction to migrate to a capture zone.
  • the separation zone may have a different ligand density or a gradient of ligand densities along the separation direction.
  • a density gradient would be parallel to the flow during use.
  • U.S. Pat. No. 5,977,345 relates to an inside-out spatial installation method for a bifunctional reagent that crosslinks a polymer matrix. More specifically, this reference relates to an activated matrix, which can accommodate and optimize the spatial installation of affinity ligands while preventing the immobilization of excess ligand in the outer strata of the hydrogel bead.
  • One aspect of the present invention is to provide a separation matrix, wherein the mass transport properties during adsorption and/or desorption have been improved. This can be achieved by a separation matrix as described in claim 1 .
  • an aspect of the invention is to provide a separation matrix, which is especially advantageous for use in large-scale purification of a target molecule.
  • a specific aspect of the present invention is to provide a separation matrix comprised of essentially spherical particles, wherein the mass transport properties differ along the radius of each such particle.
  • Another aspect of the present invention is a separation matrix, which allows elution of target molecules at an increased efficiency.
  • a further aspect of the invention is to provide a method of preparing a separation matrix comprised of a porous support, wherein a ligand density gradient is provided. This can be achieved by solvent-controlled diffusion and/or control of the reactivity of ligand during coupling thereof to the support.
  • Yet a further aspect of the invention is to provide a process of liquid chromatography, wherein the mass transport during adsorption and/or desorption is improved.
  • one aspect of the invention is to provide a process of liquid chromatography, wherein the mass transport during adsorption and/or desorption is controllable.
  • FIG. 1 is a comparative ligand distribution plot of a prior art separation matrix with an even distribution of ligands.
  • FIG. 2 shows a ligand distribution plot of negative density gradient according to the invention. A change in intensity versus lateral position appears clearly.
  • FIG. 3 shows a ligand distribution plot of negative density gradient according to the invention.
  • the shape of the ligand distribution curves was relatively similar to FIG. 2 , indicating that different size of the beads can be chosen for measurement.
  • FIG. 4 shows a ligand distribution plot of positive density gradient according to the invention.
  • the prototype in FIG. 4 has a steeper and shorter ligand gradient than FIG. 5 below.
  • FIG. 5 shows a ligand distribution plot of positive density gradient according to the invention.
  • the intensity is low at the outer parts of a bead but increases rather rapidly when going into the middle of the bead, and finally levels off.
  • FIG. 6 shows in a schematic way how the adsorption of a target molecule can be facilitated by an increasing ligand density towards the centre of a particulate separation matrix.
  • FIG. 7A -H show various illustrative chemical gradients in that can be provided in essentially spherical particles according to the invention. Two ligand kinds are shown, ligand 1 (line) and ligand 2 (broken line). The gradients are shown in diagrams having Relative density on the Y-axis and a dimensionless radius on the X-axis.
  • gradient means a change in the value of a quantity with change in a given variable, especially per unit distance, in a specified direction.
  • a “continuous and smooth” gradient means that it increases or decreases in a continuous fashion; linearly or with varying degrees of convexity or concavity.
  • a “continuous and smooth” gradient is essentially free from discontinuous steps.
  • a “radial” gradient means that the gradient increases or decreases towards the centre of the beads.
  • ligand means a chemical entity, which comprises at least one functional group capable of interaction with a target molecule.
  • functionality is also used herein for such a functional group.
  • a “ligand” may or may not comprise a spacer element, which distances the functional groups from the surface of a solid support.
  • affinity ligand means herein a ligand comprising functionalities capable of interaction via biological affinity with a target molecule, such as biotin interacting with streptavidin, an antibody interacting with an antigen etc.
  • functionalities as used herein embraces a number of the same kind of functionalities and a number of different functionalities.
  • ligand density means herein the degree of substitution of a support, such as a particle, and is commonly measured in ⁇ mol/ml resin.
  • the “surface” of a porous support refers to the outer surface as well as to the pore surfaces.
  • the present invention relates to a separation matrix comprised of ligands coupled to the surfaces of a porous support, wherein the ligands provide at least one chemical gradient in the support, which gradient may be directed across the support or be present within the support, depending on its nature.
  • Illustrative shapes of the support are e.g. membranes, monoliths and particles.
  • the present invention is a separation matrix comprised of ligands coupled to the surfaces of at least one porous particle, wherein the ligands provide at least one chemical gradient between the centre and the exterior surface of each porous particle.
  • a chemical gradient means a systematic and repeated change in any chemical property, preferably a property that is utilised in, or influence, a subsequent separation process.
  • Illustrative chemical properties are concentration, density and attraction.
  • the chemical gradient present in the particles according to the invention is preferably created in a way that improves the mass transport when the matrix is utilised for separation, such as in chromatography. Accordingly, even though heterogeneous particles may have been resulted from prior art methods of manufacture, the present invention suggests for the first time heterogeneous particles which have been specifically designed to incorporate a chemical gradient that alters and preferably improves their adsorption and/or desorption properties during a separation process.
  • Illustrative adsorption and/or desorption properties are e.g. capacity, selectivity, efficiency, intraparticle mass transport, rigidity etc.
  • the separation matrix according to the present invention is useful in separation and/or purification of practically any target molecule or compound, such as in chromatography or membrane separation.
  • target molecules are biomolecules, such as proteins; e.g. antibodies; peptides, e.g. oligopeptides and polypeptides; nucleic acids, e.g. DNA, RNA and PNA; cells; plasmids; and virus; and large and small organic molecules, such as organic drug candidates.
  • Another group of target molecules are molecules useful in food products, such as proteins or peptides useful as food additives or the like.
  • Illustrative examples of this kind of target molecules are e.g. molecules isolated from liquids originating from milk or whey products, such as lactoferrin. A process of liquid chromatography utilising the present separation matrix will be discussed in more detail below.
  • the porous particle is an essentially spherical bead.
  • the supports used in the present invention may be made of an inorganic material, such as glass or silica, or an organic material, such as one or more organic polymers. In an advantageous embodiment, the support is made from natural or synthetic polymers.
  • the support comprises one or more carbohydrate material, such as agarose, agar, cellulose, dextran, chitosan, konjac, carrageenan, gellan, alginate etc.
  • the support comprises a crosslinked carbohydrate material.
  • Carbohydrate supports are easily prepared according to standard methods, such as inverse suspension gelation (S Hjertén: Biochim Biophys Acta 79(2), 393-398 (1964). Altematively, the starting materials used to prepare the support of the present invention are commercially available products, such as SepharoseTM FF (obtainable from Amersham Biosciences AB, Uppsala, Sweden).
  • the support comprises one or more synthetic polymers, such as styrene or styrene derivatives, divinylbenzene, acrylamides, acrylate esters, methacrylate esters, vinyl esters, vinyl amides etc.
  • the support comprises one or more crosslinked synthetic polymers.
  • Such polymers are easily produced according to standard methods; see e.g. “Styrene based polymer supports developed by suspension polymerization” (R Arshady: Chimica e L'Industria 70(9), 70-75 (1988)).
  • a commercially available product such as SourceTM or SephacrylTM (Amersham Biosciences AB, Uppsala, Sweden) can be utilised as starting material to prepare the beads according to the invention.
  • the support it is made from one of the above-discussed materials, and in addition it comprises one or more high density fillers.
  • Such fillers may be of any material that presents a suitable density and compatibility with the support material, such as stainless steel.
  • This embodiment is suitable for use in an expanded bed-kind of separation process, where the separation matrix is expanded by a liquid flow applied from below.
  • the support advantageously comprises essentially spherical particles, either as separate entities in the form of a gel or as aggregates of particles. Expanded bed processes and the properties of suitable separation matrices for use therein are well known in the field of chromatography, and the skilled person can easily prepare this embodiment of the invention based on the teachings of the present invention and common technical knowledge.
  • At least one chemical gradient is a ligand density gradient formed by a changing density of ligands on the support.
  • the separation matrix comprises a single gradient which is a ligand density gradient; one ligand density gradient and one other gradient, as discussed in more detail below; or two ligand density gradients in the same or different direction, optionally combined with one or more other gradients.
  • two or more chemical gradients are present in the support and at least gradient is a ligand density gradient.
  • At least one chemical gradient is the result of varying pKa values of the functional groups of the ligands present on each porous particle.
  • at least one chemical gradient is the result of a varying net charge of the ligands present on each porous particle.
  • Such gradients can be prepared in methods analogue to the ones described in relation to ligand density gradients, wherein the pKa values and net charge are controlled instead of the density of coupled ligands.
  • the chemical gradient of the present separation matrix may be of any direction.
  • the separation matrix comprises a positive gradient, which is directed, and increases, towards the centre of the support.
  • the separation matrix comprises a negative gradient, which is directed, and decreases, towards the outer surface of the support and consequently decreasing towards the centre.
  • the present separation matrix is a chromatography matrix comprised of a plurality of essentially spherical particles, wherein each particle presents one or more gradient(s) perpendicular to the direction of the liquid flow applied in chromatography.
  • the beads are spherical or essentially spherical, there will be gradients in all directions.
  • this embodiment clearly differs in terms of direction to e.g. the above discussed U.S. Pat. No. 6,528,322 (Carlsson et al), wherein the direction of flow and the direction of the therein discussed gradient are the same.
  • a ligand density gradient is designed in porous essentially spherical particles to maximise the mass transport in the outermost part, corresponding to about 40% of the radius.
  • the outermost part corresponding to the outer 40% of the particle radius accommodates almost 80% of the total particle volume and protein capacity, respectively. This means that it will not be as important to utilise the capacity in the inner part of the particles.
  • the above suggested gradient can also be designed in a way that the slope of the ligand density gradient increases from the outer surface of the particle to about 40% of the radius and then the ligand density will decrease towards zero in the centre of the particles.
  • the support is comprised of essentially spherical particles, wherein each particle is comprised of a solid non-porous material surrounded by a porous material as discussed above and wherein at least one chemical gradient has been provided in the porous part.
  • This embodiment may advantageously be used in applications where a high flow rate is desired, since a solid inner part will improve the rigidity of the particle while an efficient separation can be obtained by using only a part of the particle, such as about 40% of the radius, as explained above.
  • At least one chemical gradient is a continuous and smooth gradient.
  • Such gradient(s) may be present only in the outer part of a support, as discussed above. Alternatively, such gradient(s) may not be present only in the inner part of a particle, such as leaving an outer shell of a porous particle wherein there is no gradient.
  • the present separation matrix may comprise two or more chemical gradients, such as one or more continuous and smooth gradients and one or more gradients that comprise discontinuous steps. The skilled person in this field will be able to decide the most advantageous extent of the chemical gradient(s) for each intended purpose, i.e. depending on which separation property it is most desired to alter or improve.
  • the ligands of each particle provide at least two different functionalities.
  • said functionalities are selected from the group that consists of cation exchange ligands, anion exchange ligands, hydrophobic interaction chromatography (HIC) ligands, reversed phase chromatography (RPC) ligands, immobilised metal chelating ligands (IMAC), thiophilic ligands, and affinity ligands.
  • Such functionalities are well known to the skilled person in this field and are easily prepared by standard methods, see e.g. Janson and Rydén in Protein Purification: Principles, High Resolution Methods, and Applications (1989 VCH Publishers, Inc).
  • the ligands may comprise groups that are partly electrostatically charged, or partly electrostatically charged, at the pH of binding of the target molecule to the matrix and either further charged or of an opposite charge at the pH of elution.
  • the ligands present zwitterionic functionalities.
  • the ligand will comprise two groups that are cationic and anionic, respectively, at a specified pH value.
  • the adsorption may then utilise ionic interactions of a first charge, while elution can be provided by a change in pH to provide desorption of the target molecule from the matrix by neutralisation of said first charge and repulsion by ionic interactions of the second charge, which is opposite from the first.
  • zwitterions are numerous and well known to the skilled person in the art, such as the common amino acids, and may be exemplified e.g. by N-[tris-(hydroxymethyl)methyl]-3-aminopropane sulphonic acid (TAPS), dimethyl glycin and glycin alanine.
  • said at least two different functionalities are present on different ligand kinds, and each such ligand kind provides a separate chemical gradient within the porous particle.
  • the present separation matrix comprises two or more chemical gradients provided by two or more different kind of ligands, such as two ligand density gradients of the same or opposed direction, wherein each ligand kind provides a separate chemical gradient.
  • the discussion below will apply equally well to the embodiment where a chemical gradient has been obtained from ligands comprising more than one functionality and to the embodiment using different kinds of ligands.
  • the present invention allows to increase the mass transport of a target molecule, such as a charged protein, in the outer part (corresponding to about 40% of the radius of an essentially spherical particle) and then prevent the protein to be transported into the centre of the support by charge repulsion.
  • the gradient of negatively charged ligands is constructed as described above.
  • the slope of the negatively charged ligand gradient increases up to a value corresponding to about 40% of the radius of an essentially spherical particle, and then the ligand density decreases towards zero in the centre of the support. This means that the ligand density is at a maximum value at a value corresponding to about 40% of the radius of an essentially spherical particle.
  • the positively charged ligand gradient may begin at a location corresponding to about 40% of the radius of an essentially spherical particle and increases toward the centre of the support.
  • This gradient is designed in a way so that the positively charged proteins are hindered by charge repulsion to penetrate the centre of the support.
  • the present invention relates to a chromatography column packed with a separation matrix comprised of ligands coupled to the surfaces of a porous support, wherein the ligands provide at least one chemical gradient within the support.
  • At least one chemical gradient is a ligand density gradient as described above.
  • the present chromatography column has been packed with a separation material as described above.
  • the chromatography columns according to the invention may be relatively small and useful for laboratory applications or of a larger size suitable for production of target molecules in large scale.
  • the column may be used for large scale purification of target molecules; for the removal of one or more undesired molecules from a liquid sample, and for analytical purposes such as diagnostics.
  • the column material and design may be adapted depending on the intended application using standard materials and technologies.
  • the present invention relates to a method of providing a separation matrix comprising ligands coupled to the surfaces of a porous support, in which method at least one ligand density gradient is provided by solvent-controlled diffusion of at least one reagent into the porous support.
  • This method is the best embodiment of manufacture of the separation matrix according to the invention.
  • reagent means any molecule or compound capable of reacting with groups present on the surface of the porous support, and may or may not comprise ligand functionalities, as will be discussed in more detail below.
  • This aspect also embraces the preparation of anyone of the above discussed chemical gradients, such as pKa gradients or net charge gradients.
  • the solvent-controlled diffusion is obtained by adding said reagent(s) from a first solvent while a second solvent is present inside the porous support, said first and second solvents presenting different solubilities.
  • the solvent-controlled diffusion is obtained by contacting a first solvent comprising said reagent(s) with the support, in the pores of which a second solvent is present, said first and second solvents presenting different solubilities.
  • the first solvent is aqueous and the second solvent is organic.
  • the first solvent is organic and the second solvent is aqueous.
  • the porous support may first be soaked in a suitable solvent, such as an organic solvent, and then drained e.g. by filtration before being contacted with a reagent solution which is not soluble, or which is difficult to solve, in the first solvent, such as an aqueous solution of reagent.
  • a suitable solvent such as an organic solvent
  • the invention also relates to an embodiment wherein one or more further conditions are adjusted to assist the diffusion in the desired direction.
  • one or more further conditions are adjusted to assist the diffusion in the desired direction.
  • this can be achieved by any of a number of available means, such as one or more conditions selected from the group of temperature; air flow; solvent properties; and concentration(s) and/or nature of the functionalities.
  • the diffusion of reagent(s) is assisted by providing an air flow through the reaction mixture during the ligand coupling.
  • the air flow is essentially continuous.
  • the separation matrix prepared according to the present method may be of any of the above-discussed shapes or formats, such as essentially spherical particles, commonly denoted beads, monoliths, filters, membranes etc.
  • the gradients provided may be any of the chemical gradients described above such as ligand density gradients. Any one of the above-discussed shapes and combinations of gradients discussed above may be prepared by the present method.
  • a ligand density gradient that decreases towards the centre of the support is provided by adding a reagent that comprises at least one functionality under diffusion-controlled conditions. This direction of gradient is also denoted a negative gradient.
  • the reagent is any compound that comprises one or more functionalities capable of acting as ligands once coupled to a surface, or useful to provide such functionalities at the surface of the support as discussed below. It is understood that “acting as ligands” refers to the capability of interacting with a target molecule once immobilised or coupled to the surface of the support.
  • the reagent or groups present on the surface of the porous support have been activated.
  • Activation and activatable groups will be discussed in more detail below, and any of the below discussed embodiments and examples are applicable here.
  • a suitable reagent e.g. a reagent comprising hydroxyl groups.
  • the surface groups of the porous support is essentially non-reactive, while the reagent has been activated, e.g. by epoxidation.
  • any embodiment of this method is covered, wherein the surface groups of the support and the added reagent are capable of reacting with each other.
  • the support presents activatable groups, which are easily activated by conventional chemistry, or activated groups capable of reacting with a reagent.
  • the support presents activated groups.
  • This embodiment is useful especially for the preparation of a gradient that increases towards the middle of the support, i.e. a positive gradient.
  • a density gradient that increases towards the centre of the support is provided by adding, in a first step, a first reagent that comprises deactivating groups under diffusion-controlled conditions and, in a second step, adding a second reagent that comprises at least one functionality.
  • a deactivating group is added to obtain surface groups which are deactivated.
  • the deactivated groups on the surface of the support cannot react with the second reagent, and no functional groups with be coupled at these sites.
  • the deactivated groups are non-reactive in respect of the second reagent that comprises functionalities.
  • the first reagent may also be denoted a “deactivating agent”.
  • the diffusion is controlled to gradually decrease towards the centre, and hence there will be an increasing capability to couple functional groups and provide ligands towards the further in you get. Since the number of available groups have been controlled by the deactivation step, in the second step, the amount of reagent is not crucial and there will be no need to control diffusion in the second step.
  • the amount of functional groups is one useful variable.
  • a mixture of one or more different functional groups is useful.
  • the reagent comprises two different functionalities in a predetermined ratio to provide to different ligands in the separation matrix. Different diffusion properties of different functionalities may then result in different chemical reagents.
  • the second aspect of the present invention also encompasses a method of preparing a separation matrix that comprises ligands coupled to the surfaces of a porous support, which method comprises the step of
  • the gradients may be generated by using a limiting amount of compound comprising functionalities (ligand) in step (c) as compared to the activated groups resulting from step (b). It is also possible to control other parameters such as the temperature, the concentration of the ligand or the type of solvent to control the diffusion and/or the reactivity of the ligand, creating gradients with different ligand substitution profiles. Using different limiting quantity of ligand can also generates different of gradient profiles. Thus, in one embodiment, the diffusion rate is controlled by adjustment of the concentration of ligand.
  • the porous support may be as discussed above in relation to the first aspect of the invention.
  • the support is comprised of at least one porous particle, preferably an essentially spherical particle, and at least one chemical gradient extends between the centre and the exterior surface of each porous particle.
  • Various general techniques for preparing a porous particle that carries ligands are well known in this field. As is easily realised, the method of choice will depend on the nature of the porous particle.
  • the activatable groups provided in step (a) may be any groups commonly used in this context, such as carboxylic groups (activatable with NHS/EDC), amines, allyl groups etc.
  • the activatable groups of step (a) are carbon-carbon double bonds.
  • the porous support may for example be particles made from a synthetic polymer, wherein double bonds such as vinyl groups left unreacted in the preparation thereof are easily available.
  • the present method also comprises to provide the activatable groups present at the surface of at least one porous particle in a step preceding step (a).
  • the allylation is easily performed following standard methods with a suitable agent, such as with allyl glycidyl ether (AGE) or allyl bromide.
  • AGE allyl glycidyl ether
  • This may for example include to allylate suitable groups such as hydroxyl groups, which are available in most natural polymers such as polysaccharides, e.g. agarose.
  • AGE allyl glycidyl ether
  • allyl bromide This may for example include to allylate suitable groups such as hydroxyl groups, which are available in most natural polymers such as polysaccharides, e.g. agarose.
  • other activatable groups are well known to the skilled person in this field, and illustrative further examples are e.g. amines, thiols, carboxy groups etc.
  • steps (a)-(c) above are replaced by a single step, wherein an activated ligand is reacted with the activatable groups present on the surface of the support.
  • This may for example involve use of a compound, which carries both a reactive group, such as an epoxide, which is available for reaction with the e.g. a hydroxyl group on the surface of the support, and one or more ligand functionalities.
  • Step (b) can be performed using any commonly used activation agent capable of rendering a carbon-carbon double bond reactive.
  • the activation agent is a free radical.
  • the activation agent comprises an electrophile, such as a halogen, e.g. bromine, chlorine or iodine, or a hydroxide thereof.
  • the activation agent used in step (b) is a halogen. Activation of a carbon-carbon double bond with a halogen or halogenating agent may result in halohydrines, which are easily converted to reactive epoxy groups in accordance with standard methods.
  • step (b) also includes to convert the halogenated product to an epoxy group.
  • the compound coupled in step (c) may also comprise an element which distances said functional group(s) from the support surface.
  • Such elements are commonly used and known as spacer elements or spacers.
  • a spacer may coupled to the surface of the particle surface before the activation thereof.
  • any such distancing element will work as a spacer, regardless of the method for its introduction, and in principle any group or compound that provides such distancing will be denoted a spacer.
  • some of the more frequently used activating schemes comprise an activating agent such as allyl glycidyl ether (AGE), which in part will be transformed into a spacer.
  • AGE allyl glycidyl ether
  • At least one chemical gradient is a continuous and smooth ligand density gradient, as discussed above in the context of the first aspect of the invention.
  • At least one chemical gradient is a ligand density gradient.
  • the present method may be repeated in order to obtain two or more chemical gradients, as discussed above.
  • the gradients are obtained more or less simultaneous, in a single process.
  • the functionalities of in step (c) provide at least two different functionalities. Such functionalities may be as described above in the context of the first aspect of the invention. In one embodiment, said at least two different functionalities are present on the same ligand, such as on a zwitterionic compound.
  • said at least two different functionalities are present on different ligand kinds, and a separate chemical gradient is provided for each such ligand kind within the support.
  • a separate chemical gradient is provided for each such ligand kind within the support.
  • Such different gradients may be as discussed above in the context of the first aspect of the invention.
  • two chemical gradients are provided in the support, one of which is a ligand density gradient. The effects and advantages of such gradients and combinations of gradients will be discussed in more detail below in the context of the process of liquid chromatography.
  • the present invention also encompasses a separation matrix prepared using the present method.
  • the present invention relates to a process of liquid chromatography, wherein a liquid comprising a target molecule is contacted with a separation matrix that comprises ligands coupled to the surfaces of a porous support and the ligands provide a chemical gradient within the support.
  • the support is comprised of at least one porous particle, and a chemical gradient extends between the centre and the exterior surface of each porous particle.
  • the gradient may be a radial gradient.
  • the nature of the separation matrix may be as described above in the context of the first aspect of the invention. The general principles behind liquid chromatography are well known to the skilled person in this field and described in various textbooks.
  • the present process further comprises a step of eluting the adsorbed target molecule from the matrix by contacting the matrix with an eluent.
  • an eluent The nature of the eluent will obviously depend upon the nature of the ligands coupled to the particles.
  • the eluent may comprise a salt gradient or a pH gradient.
  • the functional groups of the ligands are zwitterions and the elution is performed at a pH different from that used during the adsorption.
  • the ligand density increases towards the centre of the support.
  • this embodiment includes a radial gradient.
  • the gradient is of the opposite direction.
  • the present separation matrix may contain two or more chemical gradients, one of which is preferably a continuous and smooth gradient.
  • both the adsorption and the desorption processes can be improved. For example, by choosing one ligand that attracts and one ligand that repels the target molecules, the adsorption can be directed to the outer part of the support and the target molecules are prevented from penetrating the inner part of the support.
  • the gradient of the attracting ligand is adjusted to increase the mass transport of the sample molecules in the outer part of the support.
  • Another advantage of using two ligands and two different gradients is the possibility to achieve a separation of target molecules in each support, e.g. in each particle, and in this way increase the selectivity of the chromatographic process, such as a separation in a column.
  • This can, for example, be accomplished by combining one gradient of an ionexchange functionality and another gradient of a functionality that supports hydrophobic interactions, i.e. a HIC ligand.
  • the gradient of the HIC-ligands decreases towards the centre of the particles and the gradient of the ion-exchange ligand increases towards the centre.
  • hydrophilic target molecules which are oppositely charged to the ion-exchange group
  • the adsorbed target molecules are easily desorbed by gradient elution.
  • the solvent gradient should be designed in a way that the proteins adsorbed in the outer part of the particles are eluted first and the proteins adsorbed in the inner part of the particles are eluted last.
  • the present invention is useful for separation of virtually any target molecule, depending on how the separation matrix is designed.
  • the target molecule is a protein.
  • the present process of liquid chromatography may either be a process of purifying one desired target molecule from a solution, such as a fermentation broth, or a process used for purification of a liquid by removal of an undesired target molecule, such as a virus.
  • FIG. 2 shows a ligand distribution plot of CM negative gradient Sepharose BB according to the invention (Example 1), with the intensity of Nd 3+ versus radial coordinate in the bead(s).
  • Bead diameter ( ⁇ m) 130 (diamond), 160 (square), 165 (triangle), 170 (circle).
  • FIG. 4 shows a ligand distribution plot of CM positive gradient Sepharose BB according to the invention (Example 3), with the intensity of Nd 3+ versus lateral position in the beads.
  • Bead diameter ( ⁇ m) 130 (diamond), 155 (square), 175 (triangle).
  • FIG. 5 shows a ligand distribution plot of CM positive gradient Sepharose BB according to the invention (Example 4), with the intensity of Nd 3+ versus lateral position in the beads.
  • Bead diameter ( ⁇ m) 130 (diamond), 150 (square), 160 (triangle).
  • FIG. 4 and 5 show results from the two positive gradient prototypes of CM Sepharose BB.
  • the intensity is low at the outer parts of a bead but increases rather rapidly when going into the middle of the bead, and finally levels off.
  • the prototype in FIG. 4 has a steeper and shorter ligand gradient. As above, the bead size had no effect on the results.
  • FIG. 6 shows in a schematic way how the adsorption of a target molecule can be facilitated by an increasing ligand density towards the centre of a particulate separation matrix.
  • the drawing is intended to illustrate an embodiment where the functional groups of the ligands are surrounded by a field, such as the field surrounding a charged functionality.
  • the arrows indicate how an increasing force will facilitate the mass transport into the particle.
  • FIG. 7A -H shows illustrative examples of chemical gradients provided according to the present invention.
  • FIG. 7A shows a gradient which increases towards the centre of the support, which gradient starts within the support and hence leaves an outer part of the particle without ligands;
  • FIG. 7B shows a gradient which decreases towards the centre of the support;
  • FIG. 7C shows a gradient which reaches a peak value halfway to the centre of the support;
  • FIG. 7D shows a gradient which decreases towards the centre of the support, i.e. where the ligands are present at a higher concentration in the outer part of the support;
  • FIG. 7E shows two gradients of opposite direction within the support;
  • FIG. 7F shows two gradients of the same direction but of different inclination within the support;
  • FIG. 7A shows a gradient which increases towards the centre of the support, which gradient starts within the support and hence leaves an outer part of the particle without ligands
  • FIG. 7B shows a gradient which decreases towards the centre of the
  • FIG. 7G illustrates two gradients, one is in the centre of the particle and one surrounding the centre, similar to FIG. 7C ; and FIG. 7H shows a support, wherein one ligand or functionality describes a planar curve and the other is a gradient similar to the one described in FIG. 7B .
  • a support having the kind of gradients shown in FIG. 7H can e.g. be obtained by starting from a support material which has already been functionalised with ligand to a constant substitution degree and subsequently applying the method according to the invention to provide a gradient.
  • Volumes of matrix refer to settled bed volume.
  • stirring is referring to a suspended, motor-driven stirrer since the use of magnet bar stirrer is prompt to damage the beads.
  • Small-scale reactions up to 20 ml or g of gel) were performed in closed vials and stirring refers to the use of a shaking table. Conventional methods were used for the analysis of the functionality and the determination of the degree of allylation, or the degree of substitution of ion exchanger groups on the beads.
  • a porous support is easily provided with activatable groups using allyl glycidyl ether as follows in this example. 170 ml of Sepharose Big Beads (BB) (obtainable from Amersham Biosciences, Uppsala, Sweden), were suction dried to 130 g and mixed with a 50% aqueous solution of NaOH, 1.7 g of NaBH 4 , 21 g of Na 2 SO 4 , and 20 ml of water. The mixture was stirred for 1 hour at 50° C. Allyl glycidyl ether (150 ml) was added and the suspension was left at 50° C. under vigorous stirring for an additional 16 hours.
  • BB Sepharose Big Beads
  • a porous support comprising activatable groups is easily activated as follows in this example. Bromine was added to a stirred suspension of 5 ml of allyl activated SepharoseTM BB (0.316 mmol allyl groups/ml drained gel), 0.5 g of AcONa and 5 ml of distilled water, until a persistent yellow colour was obtained. Sodium formate was then added until the suspension was fully decolourised. The reaction mixture was filtered and the gel washed with 50 ml of distilled water, followed by ethanol and finally toluene. The well drained gel was then directly transferred to a reaction vessel and further reacted with the ligand.
  • Bromine was added to a stirred suspension of 5 ml of allyl activated SepharoseTM BB (0.316 mmol allyl groups/ml drained gel), 0.5 g of AcONa and 5 ml of distilled water, until a persistent yellow colour was obtained. Sodium formate was then added until the suspension was fully
  • the gradients can be conveniently obtained by limiting the diffusion of different reagents in the support using two different solvents in the support and outside.
  • the functionalities here cationic groups were introduced on the matrix directly via the sulphur atom of the 3-mercaptopropionic acid.
  • 3-mercaptopropionic acid is the reagent, i.e. the compound that comprises functionalities.
  • Ligand gradients directed and hence increasing towards the centre of the support are referred here as positive gradients and ligand gradients directed towards the outer surface of the support and consequently decreasing towards the centre are referred as negative gradients.
  • the coupling to the matrix was realised via bromination of the allyl group and nucleophilic substitution under basic conditions.
  • a separation matrix comprising a density gradient of carboxymethyl (CM) cation-exchange ligands was prepared as follows.
  • a 4 g quantity of bromine activated gel in toluene (0.316 mmol allyl groups/ml drained gel) was filtered and transferred to a reaction vial containing a solution of 3-mercaptopropionic acid (0.07 ml) in water (5 ml) that had been adjusted to pH 11.5 by addition of 2M NaOH (0.8 ml) and 0.5M Na 2 CO 3 (4 ml).
  • the reaction was left 16 hours under stirring at 50° C. and with a continuous air flow through the mixture (30 ml/min) via a capillary. After filtration of the reaction mixture, the gel was washed with 3 ⁇ 30 ml of distilled water. Titration was used to confirm the average substitution degree, while the presence of ligand gradients is confirmed as below.
  • a separation matrix comprising a density gradient of carboxymethyl (CM) cation-exchange ligands was prepared as follows.
  • a 4 g quantity of bromine activated gel in hexane (0.316 mmol allyl groups/ml drained gel) was filtered and transferred to a reaction vial containing a solution of 3-mercaptopropionic acid (0.07 ml) in water (5 ml) that had been adjusted to pH 11.5 by addition of 2M NaOH (0.8 ml) and 0.5M Na 2 CO 3 (4 ml).
  • the reaction was left 16 hours under stirring at 40° C. and with a continuous air flow through the mixture (30 ml/min) via a capillary.
  • the gel was washed with 3 ⁇ 30 ml of distilled water. Titration was used to confirm the average substitution degree, while the presence of ligand gradients is confirmed as below.
  • a separation matrix comprising a density gradient of carboxymethyl (CM) cation-exchange ligands was prepared as follows.
  • a 5 g quantity of bromine activated gel in toluene (0.316 mmol allyl groups/ml drained gel) was filtered and transferred to a reaction vial containing a solution of thioglycerol (105 ⁇ l) in water (10 ml) that had been adjusted to pH 10.5 by addition of 2M NaOH (0.4 ml) and 0.5M Na 2 CO 3 (4 ml).
  • the reaction was left 16 hours under stirring at 50° C. and with a continuous air flow through the mixture (23 ml/min) via a capillary.
  • the gel was washed with 3 ⁇ 30 ml of distilled water and transferred to a reaction vial containing a solution of 3-mercaptopropionic acid (1.5 ml) in water (5 ml) that had been adjusted to pH 12.5 by addition of a 50% aq. solution of NaOH. The reaction was left 16 hours under stirring at 50° C. After filtration of the reaction mixture, the gel was washed with 3 ⁇ 30 ml of distilled water. Titration was used to confirm the average substitution degree, while the presence of ligand gradients is confirmed as below.
  • a separation matrix comprising a density gradient of carboxymethyl (CM) cation-exchange ligands was prepared as follows.
  • a 5 g quantity of bromine activated gel in hexane (0.316 mmol allyl groups/ml drained gel) was filtered and transferred to a reaction vial containing a solution of thioglycerol (105 ⁇ l) in water (10 ml) that had been adjusted to pH 10.5 by addition of 2M NaOH (0.4 ml) and 0.5M Na 2 CO 3 (4 ml).
  • the reaction was left 16 hours under stirring at 40° C. and with a continuous air flow through the mixture (46 ml/min) via a capillary.
  • the gel was washed with 3 ⁇ 30 ml of distilled water and transferred to a reaction vial containing a solution of 3-mercaptopropionic acid (1.5 ml) in water (5 ml) that had been adjusted to pH 12.5 by addition of a 50% aq. solution of NaOH. The reaction was left 16 hours under stirring at 50° C. After filtration of the reaction mixture, the gel was washed with 3 ⁇ 30 ml of distilled water. Titration was used to confirm the average substitution degree, while the presence of ligand gradients is confirmed as below.
  • CRS Confocal Raman Spectroscopy
  • CM Sepharose BB 120 Homogenous CM Sepharose BB, 43 Negative gradient U1282072 CM Sepharose BB, 16 Negative gradient U1282073 CM Sepharose BB, 137 Positive gradient U1282081A CM Sepharose BB, 151 Positive gradient U1282081B Apparatus
  • a confocal Raman microscope system (Renishaw, model 1000) was used.
  • the Raman system (based on a dispersive grating) was equipped with a near-infrared diode laser with an excitation wavelength of 785 nm, an optical microscope (Leica) and a CCD detector.
  • the optical microscope was equipped with several air objectives (used for wavelength calibration) and one water-immersion type (used for the media measurements).
  • the spectrometer wavelength (wave number) scale has to be calibrated.
  • the surface of a silicon wafer was zoomed in visually with the air objective (50 ⁇ ).
  • the laser spot (seen by a video camera) was further focused to a small and bright spot. If needed, the laser spot position was adjusted. Finally, the detector signal area was checked. A spectrum was obtained and the 520 cm ⁇ 1 band was used for calibration. If needed, the scale was adjusted.
  • the prepared sample was mounted in the microscope and the water-immersion objective (63 ⁇ ) was positioned in the water drop by moving the sample stage upwards.
  • a bead was zoomed in and focused with the microscope to obtain a confocal plane (in focus) in the middle of the bead.
  • the sample stage was moved to set a measurement start point on the x-scale (at the edge of the bead). After switching to laser mode, a spectrum was obtained according to the parameters below. After switching to visual mode, the measurement point was moved vertically to a new position and so forth. After taking a number of spectra along the particle radius, the intensity of the fluorescent signal of Nd 3+ was evaluated in each spectrum.
  • FIG. 1 shows a ligand distribution plot of a normal prototype of CM Sepharose BB (CDM). The results show that the intensity is almost the same over the entire diameter of the bead, which is expected.
  • Example 1 The results of Example 1 are shown in FIG. 2 , with the intensity of Nd 3+ versus radial coordinate in the bead(s).
  • the ligand distribution plot shows a change in intensity of Nd 3+ versus lateral position. The intensity is high at the outer parts of a bead but gradually decreases when going into the middle of the bead, and finally levels off and/or becomes to low to be measured. In this case (and further on), measurements were done only about one radius of the beads.
  • Example 2 The results of Example 2 are shown in FIG. 3 .
  • the results resemble FIG. 2 , but the change in intensity is different in lateral position.
  • different sizes of beads were analyzed.
  • the shape of the ligand distribution curves was relatively similar indicating that different size of the beads can be chosen for measurement.
  • Examples 3 and 4 positive gradients
  • the results of Examples 3 and 4 are shown in FIG. 4 and 5 , respectively.
  • the intensity is low at the outer parts of a bead but increases rather rapidly when going into the middle of the bead, and finally levels off.
  • the prototype in FIG. 4 has a steeper and shorter ligand gradient. As above, the bead size had no effect on the results.
  • carboxylic groups were introduced on the matrix with thiol-containing derivatives, but derivatives containing other reactive nucleophilic groups can as well be used.
  • Bromine was added to a stirred suspension of 100 ml of allyl activated SepharoseTM 6 FF (0.3 mmol of allyl/ml), 4 g of AcONa and 100 ml of distilled water, till a persistent yellow colour was obtained.
  • Sodium formate was then added till the suspension was fully decolourised.
  • reaction mixture was filtered and the gel washed with 500 ml of distilled water.
  • the activated gel was then directly transferred to 4 distinct reaction vessels:
  • the anion exchanger groups were introduced on the matrix directly by immobilisation of a tertiary amine, but ligands containing other reactive nucleophilic groups and can as well be used as long as they also present an anion exchanger group or the possibility to generate one.
  • Bromine was added to a stirred suspension of 100 ml of allyl activated SepharoseTM 6 FF (0.3 mmol of allyl/ml), 4 g of AcONa and 100 ml of distilled water, till a persistent yellow colour was obtained.
  • Sodium formate was then added till the suspension was fully decolourised.
  • reaction mixture was filtered and the gel washed with 500 ml of distilled water.
  • the activated gel was then directly transfer to 4 distinct reaction vessels:
  • the reaction was terminated by washing the gel on a glass filter funnel with 400 mL water, 80 ml 1M Sodium chloride and another 400 mL of water.
  • the reaction was terminated by washing the gel on a glass filter funnel with 400 mL water, 80 ml 1M Sodium chloride and another 400 mL of water.
  • the reaction was terminated by washing the gel on a glass filter funnel with 400 mL water, 80 ml 1M Sodium chloride and another 400 mL of water.
  • the reaction was terminated by washing the gel on a glass filter funnel with 400 mL water, 80 ml 1M Sodium chloride and another 400 mL of water.
  • the increasing gradient was realised by first creating a decreasing gradient of a neutral ligand and the resulting gel was further derivatised on the remaining active groups by the chromatographically active ligand.
  • Bromine was added to a stirred suspension of 100 ml of allyl activated SepharoseTM 6 FF (0.3 mmol of allyl/ml), 4 g of AcONa and 100 ml of distilled water, till a persistent yellow colour was obtained.
  • Sodium formate was then added till the suspension was fully decolourised.
  • reaction mixture was filtered and the gel washed with 500 ml of distilled water.
  • the activated gel was then directly transfer to 4 distinct reaction vessels:
  • reaction was left 1 hour under stirring at 50° C. After 1 hour the reaction was treated with an aqueous solution (5 ml dist.water) of 1.6 ml of thiopropionic acid (3 equivalents per allyl group) and 2.4 g of NaCl which pH was adjusted to 11,5 with 50% aq. NaOH before the addition. The reaction was then left 18 hours at 50° C.
  • reaction was left 1 hour under stirring at 20° C. After 1 hour the reaction was treated with an aqueous solution (5 ml dist.water) of 1.6 ml of thiopropionic acid (3 equivalents per allyl group) and 2.4 g of NaCl which pH was adjusted to 11,5 with 50% aq. NaOH before the addition. The reaction was then left 18 hours at 50° C.
  • reaction was left 1 hour under stirring at 50° C. After 1 hour the reaction was treated with an aqueous solution (5 ml dist.water) of 1.6 ml of thiopropionic acid (3 equivalents per allyl group) and 2.4 g of NaCl which pH was adjusted to 11,5 with 50% aq. NaOH before the addition. The reaction was then left 18 hours at 50° C.
  • reaction was left 1 hour under stirring at 20° C. After 1 hour the reaction was treated with an aqueous solution (5 ml dist.water) of 1.6 ml of thiopropionic acid (3 equivalents per allyl group) and 2.4 g of NaCl which pH was adjusted to 11,5 with 50% aq. NaOH before the addition. The reaction was then left 18 hours at 50° C.
  • Bromine was added to a stirred suspension of 100 ml of allyl activated SepharoseTM 6 FF (0.3 mmol of allyl/ml), 4 g of AcONa and 100 ml of distilled water, till a persistent yellow colour was obtained.
  • Sodium formate was then added till the suspension was fully decolourised.
  • reaction mixture was filtered and the gel washed with 500 ml of distilled water.
  • the activated gel was then directly transfer to 4 distinct reaction vessels:
  • reaction was left 1 hour under stirring at 50° C. After 1 hour the reaction was treated with an aqueous solution (5 ml dist.water) of 2.86 g of trimethylammonium chloride (5 equivalents per allyl group) and 2.4 g of NaCl which pH was adjusted to 11.5 with 50% aq. NaOH before the addition. The reaction was then left 18 hours at 50° C.
  • the reaction was terminated by washing the gel on a glass filter funnel with 400 mL water, 80 ml 1M Sodium chloride and another 400 mL of water.
  • reaction was left 1 hour under stirring at 20° C. After 1 hour the reaction was treated with an aqueous solution (5 ml dist.water) of 2.86 g of trimethylammonium chloride (5 equivalents per allyl group) and 2.4 g of NaCl which pH was adjusted to 11.5 with 50% aq. NaOH before the addition. The reaction was then left 18 hours at 50° C.
  • the reaction was terminated by washing the gel on a glass filter funnel with 400 mL water, 80 ml 1M Sodium chloride and another 400 mL of water.
  • reaction was left 1 hour under stirring at 50° C. After 1 hour the reaction was treated with an aqueous solution (5 ml dist.water) of 2.86 g of trimethylammonium chloride (5 equivalents per allyl group) and 2.4 g of NaCl which pH was adjusted to 11.5 with 50% aq. NaOH before the addition. The reaction was then left 18 hours at 50° C.
  • the reaction was terminated by washing the gel on a glass filter funnel with 400 mL water, 80 ml 1M Sodium chloride and another 400 mL of water.
  • reaction was left 1 hour under stirring at 20° C. After 1 hour the reaction was treated with an aqueous solution (5 ml dist.water) of 2.86 g of trimethylammonium chloride (5 equivalents per allyl group) and 2.4 g of NaCl which pH was adjusted to 11.5 with 50% aq. NaOH before the addition. The reaction was then left 18 hours at 50° C. The reaction was terminated by washing the gel on a glass filter funnel with 400 mL water, 80 ml 1M Sodium chloride and another 400 mL of water.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
US10/575,945 2003-10-31 2004-11-01 Novel separation matrix Abandoned US20070125711A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0302911A SE0302911D0 (sv) 2003-10-31 2003-10-31 Novel separation matrix
SE0302911.3 2003-10-31
PCT/SE2004/001583 WO2005042131A1 (en) 2003-10-31 2004-11-01 Novel separation matrix

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/SE2004/001583 A-371-Of-International WO2005042131A1 (en) 2003-10-31 2004-11-01 Novel separation matrix

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/692,671 Division US8070958B2 (en) 2003-10-31 2010-01-25 Separation matrix having a ligand density gradient

Publications (1)

Publication Number Publication Date
US20070125711A1 true US20070125711A1 (en) 2007-06-07

Family

ID=29580205

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/575,945 Abandoned US20070125711A1 (en) 2003-10-31 2004-11-01 Novel separation matrix
US12/692,671 Expired - Fee Related US8070958B2 (en) 2003-10-31 2010-01-25 Separation matrix having a ligand density gradient

Family Applications After (1)

Application Number Title Priority Date Filing Date
US12/692,671 Expired - Fee Related US8070958B2 (en) 2003-10-31 2010-01-25 Separation matrix having a ligand density gradient

Country Status (5)

Country Link
US (2) US20070125711A1 (enExample)
EP (1) EP1677887A1 (enExample)
JP (2) JP2007510153A (enExample)
SE (1) SE0302911D0 (enExample)
WO (1) WO2005042131A1 (enExample)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070187313A1 (en) * 2005-12-16 2007-08-16 Akzo Nobel N.V. Silica based material
US20090216150A1 (en) * 2008-02-25 2009-08-27 Lee Reichel Method and Apparatus For Inserting Biopsy Site Marker In Marker Body
US20110155668A1 (en) * 2008-07-08 2011-06-30 Ge Healthcare Bio-Sciences Ab Separation medium for chromatography of various biomolecules
US20130040809A1 (en) * 2010-04-26 2013-02-14 Ge Healthcare Bio-Sciences Ab Method for production of chromatography media
US20140227766A1 (en) * 2011-06-08 2014-08-14 Agency For Science, Technology And Research Purification of biological products by constrained cohydration chromatography
US20160367966A1 (en) * 2014-03-14 2016-12-22 Ge Healthcare Bioprocess R&D Ab Separation matrices for purification of biological particles

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0502485L (sv) * 2005-11-09 2007-05-10 Peter Viberg Partiklar
IN2012DN02539A (enExample) * 2009-10-12 2015-08-28 Ge Healthcare Bio Sciences Ab
SG10201701224UA (en) * 2012-03-12 2017-04-27 Merck Patent Gmbh Removal of protein aggregates from biopharmaceutical preparations in a flowthrough mode
CN105980047B (zh) * 2013-12-12 2019-01-04 Emd密理博公司 使用含丙烯酰胺的过滤器分离蛋白

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3983299A (en) * 1974-03-04 1976-09-28 Purdue Research Foundation Bonded carbohydrate stationary phases for chromatography
US5561097A (en) * 1994-04-28 1996-10-01 Minnesota Mining And Manufacturing Company Method of controlling density of ligand coupled onto supports and products produced therefrom
US5977345A (en) * 1998-03-03 1999-11-02 Virginia Tech Intellectual Properties, Inc Inside-out crosslinked and commercial-scale hydrogels, and sub-macromolecular selective purification using the hyrdogels
US6090288A (en) * 1996-02-19 2000-07-18 Amersham Pharmacia Biotech Ab Process for chromatographic separation of peptides and nucleic acid, and new high affinity ion exchange matrix
US6258548B1 (en) * 1997-06-05 2001-07-10 A-Fem Medical Corporation Single or multiple analyte semi-quantitative/quantitative rapid diagnostic lateral flow test system for large molecules
US6426315B1 (en) * 1997-03-04 2002-07-30 Amersham Pharmacia Biotech Ab Process for introducing a functionality
US6528322B1 (en) * 1999-08-06 2003-03-04 Pharmacia Ab Analytical method and apparatus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652348A (en) * 1994-09-23 1997-07-29 Massey University Chromatographic resins and methods for using same
WO2002070111A2 (en) 2001-03-07 2002-09-12 Syddansk Universitet Method for the manufacture of gradient gels and method for analysing biomolecules on ultra-long ipg gels

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3983299A (en) * 1974-03-04 1976-09-28 Purdue Research Foundation Bonded carbohydrate stationary phases for chromatography
US5561097A (en) * 1994-04-28 1996-10-01 Minnesota Mining And Manufacturing Company Method of controlling density of ligand coupled onto supports and products produced therefrom
US6090288A (en) * 1996-02-19 2000-07-18 Amersham Pharmacia Biotech Ab Process for chromatographic separation of peptides and nucleic acid, and new high affinity ion exchange matrix
US6426315B1 (en) * 1997-03-04 2002-07-30 Amersham Pharmacia Biotech Ab Process for introducing a functionality
US6258548B1 (en) * 1997-06-05 2001-07-10 A-Fem Medical Corporation Single or multiple analyte semi-quantitative/quantitative rapid diagnostic lateral flow test system for large molecules
US5977345A (en) * 1998-03-03 1999-11-02 Virginia Tech Intellectual Properties, Inc Inside-out crosslinked and commercial-scale hydrogels, and sub-macromolecular selective purification using the hyrdogels
US6528322B1 (en) * 1999-08-06 2003-03-04 Pharmacia Ab Analytical method and apparatus

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070187313A1 (en) * 2005-12-16 2007-08-16 Akzo Nobel N.V. Silica based material
US9308520B2 (en) * 2005-12-16 2016-04-12 Akzo Nobel N.V. Silica based material
US20090216150A1 (en) * 2008-02-25 2009-08-27 Lee Reichel Method and Apparatus For Inserting Biopsy Site Marker In Marker Body
US20110155668A1 (en) * 2008-07-08 2011-06-30 Ge Healthcare Bio-Sciences Ab Separation medium for chromatography of various biomolecules
US9155980B2 (en) 2008-07-08 2015-10-13 Ge Healthcare Bio-Sciences Ab Separation medium for chromatography of various biomolecules
US20130040809A1 (en) * 2010-04-26 2013-02-14 Ge Healthcare Bio-Sciences Ab Method for production of chromatography media
US9259729B2 (en) * 2010-04-26 2016-02-16 Ge Healthcare Bio-Sciences Ab Method for production of chromatography media
US20140227766A1 (en) * 2011-06-08 2014-08-14 Agency For Science, Technology And Research Purification of biological products by constrained cohydration chromatography
US9809639B2 (en) * 2011-06-08 2017-11-07 Agency For Science, Technology And Research Purification of biological products by constrained cohydration chromatography
US20160367966A1 (en) * 2014-03-14 2016-12-22 Ge Healthcare Bioprocess R&D Ab Separation matrices for purification of biological particles
US11285460B2 (en) * 2014-03-14 2022-03-29 Cytiva Bioprocess R&D Ab Separation matrices for purification of biological particles

Also Published As

Publication number Publication date
US8070958B2 (en) 2011-12-06
SE0302911D0 (sv) 2003-10-31
WO2005042131A1 (en) 2005-05-12
US20100130354A1 (en) 2010-05-27
EP1677887A1 (en) 2006-07-12
JP2012037530A (ja) 2012-02-23
JP2007510153A (ja) 2007-04-19

Similar Documents

Publication Publication Date Title
US8070958B2 (en) Separation matrix having a ligand density gradient
Zou et al. Monolithic stationary phases for liquid chromatography and capillary electrochromatography
KR102868557B1 (ko) 대기공 아가로스
US10562007B2 (en) Separation matrix
CN102015094B (zh) 层析介质
Johansson et al. Preparation and characterization of prototypes for multi-modal separation aimed for capture of positively charged biomolecules at high-salt conditions
CN101939094B (zh) 分离介质的制备方法
US8685248B2 (en) Purification of immunoglobulins
US20110313147A1 (en) Chromatographic material for the absorption of proteins at physiological ionic strength
JP5826180B2 (ja) 分離マトリックス
US20110155668A1 (en) Separation medium for chromatography of various biomolecules
Ali et al. Monolithic silica stationary phases in liquid chromatography
JP2006520910A (ja) ｐＨ応答性高分子の使用
WO2007027139A1 (en) Manufacture of chromatography matrices

Legal Events

Date Code Title Description
AS Assignment

Owner name: GE HEALTHCARE BIO-SCIENCES AB, SWEDEN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BERGSTROM, JAN;GLAD, GUNNAR;JOHANSSON, BO-LENNART;AND OTHERS;REEL/FRAME:017545/0959

Effective date: 20060404

STCB Information on status: application discontinuation

Free format text: EXPRESSLY ABANDONED -- DURING EXAMINATION